Literature DB >> 21440354

Prevalence and geographic variations in asthma symptoms in children and adolescents in Galicia (Spain).

Angel López-Silvarrey-Varela1, Sonia Pértega-Díaz, Santiago Rueda-Esteban, Juan Manuel Sánchez-Lastres, Miguel Angel San-José-González, Manuel Sampedro-Campos, Teresa Pérez-Castro, Luciano Garnelo-Suárez, Luis Bamonde-Rodríguez, Javier López-Silvarrey-Varela, Javier González-Barcala.   

Abstract

OBJECTIVES: To determine the prevalence and geographic variations of the symptoms associated with asthma in Galician children and adolescents. POPULATION AND METHODS: A cross-sectional epidemiological study following ISAAC (International Study of Asthma and Allergies in Childhood) methodology, and using a written questionnaire distributed in schools. The study sample included 10,371 6-7 year-old children and 10,372 13-14 year-old adolescents, all of them from Galician Health Areas. A logistic regression model was used to analyse geographic variations.
RESULTS: In the 6-7 year-old group, wheezing in the last 12 months varied from 11.4% (Santiago) to 15.7% (Vigo) and in the adolescents varied from 8.8% (Ourense) to 18.8% (Vigo). The distribution by gender showed a predominant significance in 6-7 year-old males (P<.001), and near to be statistically significant in 13-14 year-old females (P=.08). The risk (odds ratio [OR]) of wheezing in the last 12 months in the area with highest prevalence in comparison with the area of lowest prevalence was 1.45 (95% Confidence Interval [CI], 1.12-1.88) for children and 2.39 (95% CI, 1.82-3.13) for adolescents. The estimated prevalence of asthma in the Autonomous Community of Galicia was 13.6% in younger children and 12.2% in adolescents.
CONCLUSIONS: The prevalence of wheezing in the last 12 months in the different areas of Galicia is considerably higher than the rest of Spanish ISAAC cities in the 6-7 years group and very similar in the 13-14 years group, except in Vigo where it is considerably higher. We found a clearly defined geographic pattern in the adolescent group, with higher prevalences in coastal areas than in the interior.
Copyright © 2010 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21440354     DOI: 10.1016/j.arbres.2011.01.009

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  7 in total

1.  The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids.

Authors:  Francisco-Javier Gonzalez-Barcala; Juan-Jose Nieto-Fontarigo; Paula Mendez-Brea; Francisco-Javier Salgado
Journal:  ERJ Open Res       Date:  2022-05-30

Review 2.  Operational definitions of asthma in recent epidemiological studies are inconsistent.

Authors:  Ana Sá-Sousa; Tiago Jacinto; Luís Filipe Azevedo; Mário Morais-Almeida; Carlos Robalo-Cordeiro; António Bugalho-Almeida; Jean Bousquet; João Almeida Fonseca
Journal:  Clin Transl Allergy       Date:  2014-08-04       Impact factor: 5.871

3.  Models for estimating and projecting global, regional and national prevalence and disease burden of asthma: a systematic review.

Authors:  Mohammad Romel Bhuia; Md Atiqul Islam; Bright I Nwaru; Christopher J Weir; Aziz Sheikh
Journal:  J Glob Health       Date:  2020-12-30       Impact factor: 4.413

4.  Analysis of the Consumption of Drugs Prescribed for the Treatment of Asthma in Belgian Children.

Authors:  Natacha Biset; Wies Kestens; Dominique Detemmerman; Murielle Lona; Güngör Karakaya; Ann Ceuppens; Stéphanie Pochet; Carine De Vriese
Journal:  Int J Environ Res Public Health       Date:  2022-01-04       Impact factor: 3.390

5.  Association of rhinitis with asthma prevalence and severity.

Authors:  Antonio Acevedo-Prado; Teresa Seoane-Pillado; Angel López-Silvarrey-Varela; Francisco-Javier Salgado; María-Jesus Cruz; Ana Faraldo-Garcia; Juan-Jose Nieto-Fontarigo; Sonia Pértega-Díaz; J Sanchez-Lastres; Miguel-Angel San-José-González; Luis Bamonde-Rodríguez; Luciano Garnelo-Suárez; Teresa Pérez-Castro; Manuel Sampedro-Campos; Francisco-Javier Gonzalez-Barcala
Journal:  Sci Rep       Date:  2022-04-16       Impact factor: 4.996

6.  A budget impact analysis of Spiromax(®) compared with Turbuhaler(®) for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions.

Authors:  Josep Darbà; Gabriela Ramírez; Juan L García-Rivero; Sagrario Mayoralas-Alises; José Francisco Pascual; Albert Roger; Diego Vargas; Adi Bijedic
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-06

7.  Operational definitions of paediatric asthma used in epidemiological studies: A systematic review.

Authors:  Mohammad Shahidul Islam; Samin Huq; Salahuddin Ahmed; Sudipto Roy; Jürgen Schwarze; Aziz Sheikh; Samir K Saha; Steve Cunningham; Harish Nair
Journal:  J Glob Health       Date:  2021-07-17       Impact factor: 4.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.